Found 27 results
Author [ Title(Desc)] Type Year
Filters: Author is Mendizabal, A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
C. A. Keever-Taylor, Devine, S. M., Soiffer, R. J., Mendizabal, A., Carter, S., Pasquini, M. C., Hari, P. N., Stein, A., Lazarus, H. M., Linker, C., Goldstein, S. C., Stadtmauer, E. A., and O'Reilly, R. J., Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303, Biol Blood Marrow Transplant, vol. 18, pp. 690-697, 2012.
M. Pasquini, Devine, S., Mendizabal, A., Baden, L., Wingard, J., Lazarus, H., Appelbaum, F., Keever-Taylor, C., O'Reilly, R., and Soiffer, R., Comparative Effectiveness Analysis of CD34+ Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts on Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Myeloid Leukemia (AML) in Complete Remiss (Poster)., in BMT Tandem Meeting, Orlando, FL, 2010.
M. Pasquini, Devine, S., Mendizabal, A., Baden, L. R., Wingard, J., Lazarus, H. M., Appelbaum, F. R., Keever-Taylor, C. A., Horowitz, M. M., Carter, S., O'Reilly, R. J., and Soiffer, R., Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy as Graft-Versus-Host Disease Prophylaxis for Patients with Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transpl, J Clin Oncol, vol. 30, pp. 3194-3201, 2012.
J. M. Hare, Fishman, J. E., Gerstenblith, G., Velazquez, D. L. Difede, Zambrano, J. P., V, S., Tracy, M., Ghersin, E., Johnston, P., ,, Davis-Sproul, J., Schulman, I., Byrnes, J., Mendizabal, A., Lowery, M., ,, McNiece, I. K., and Heldman, A. W., Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial, JAMA, vol. 308, pp. 2369-2379, 2012.
K. M. Page, Zhang, L., Mendizabal, A., Wease, S., Carter, S., Shoulars, K., Gentry, T., Balber, A. E., and Kurtzberg, J., The Cord Blood Apgar: A Novel Scoring System to Optimize Selection of Banked Cord Blood Grafts for Transplantation (CME)., Transfusion, vol. 52, pp. 272-283, 2012.
M
M. Eapen, O'Donnell, P., Brunstein, C. G., Wu, J., Barowski, K., Mendizabal, A., and Fuchs, E. J., Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies, Biol Blood Marrow Transplant, vol. 20, pp. 1485-1492, 2014.
A. Leen, Bollard, C., Mendizabal, A., Shpall, E., Szabolcs, P., Antin, J., Kapoor, N., Pai, S. Y., Grilley, B., Gee, A., Brenner, M., Rooney, C., and Heslop, H., Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT), presented at the 2011, Honolulu, Hawaii, 2011.
, Mendizabal, A., Shpall, E., Szabolcs, P., Antin, J., Kapoor, N., Heaton, C., Grilley, B., Gee, A., Brenner, M., Rooney, C., and Heslop, H., Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV after Hemopoietic Stem Cell Transplantation (HSCT)., in American Society of Hematology 52nd Annual Meeting and Exposition, Orlando, Fl, 2010.
W. Saber, Le Rademacher, J., Sekeres, M., Logan, B., Lewis, M., Mendizabal, A., Leifer, E., Appelbaum, F. R., Horowitz, M. M., Nakamura, R., and Cutler, C. S., Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*, Biol Blood Marrow Transplant, vol. 20, pp. 1566-1572, 2014.
P. Tewari, Martin, P. L., Mendizabal, A., Parikh, S. H., Page, K. M., Driscoll, T. A., Malech, H. L., Kurtzberg, J., and Prasad, V. K., Myeloablative Transplantation Using Either Cord Blood or Bone Marrow Leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in Chronic Granulomatous Disease, Biol Blood Marrow Transplant, vol. 18, pp. 1368-1377, 2012.
R
J. M. Hare, DiFede, D. L., Rieger, A. C., Florea, V., Landin, A. M., El-Khorazaty, J., Khan, A., Mushtaq, M., Lowery, M. H., Byrnes, J. J., Hendel, R. C., Cohen, M. G., Alfonso, C. E., Valasaki, K., Pujol, M. V., Golpanian, S., Ghersin, E., Fishman, J. E., Pattany, P., Gomes, S. A., Delgado, C., Miki, R., Abuzeid, F., Vidro-Casiano, M., Premer, C., Medina, A., Porras, V., Hatzistergos, K. E., Anderson, E., Mendizabal, A., Mitrani, R., and Heldman, A. W., Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial, J Am Coll Cardiol, vol. 69, no. 5, pp. 526-537, 2017.
J. Wingard, Carter, S., Walsh, T., Kurtzberg, J., Small, T., Baden, L., Gersten, I., Mendizabal, A., Leather, H., Confer, D., Maziarz, R., Stadtmauer, E., Bolanos-Meade, J., Brown, J., DiPersio, J., Boeckh, M., and Marr, K., Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation, Blood, vol. 116, pp. 5111-5118, 2010.
M. Mushtaq, DiFede, D., Golpanian, S., Khan, A., Gomes, S., Mendizabal, A., Heldman, A., and Hare, J. M., Rationale and Design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (The POSEIDON-DCM Study) [..], J Cardiovasc Transl Res, vol. 7, pp. 769-780, 2014.
B. Trachtenberg, Velazquez, D., Williams, A., McNiece, I., Fishman, J., Nguyen, K., Rouy, D., Altman, P., Schwarz, R., Mendizabal, A., Oskouei, B., Byrnes, J., Soto, V., Tracy, M., Zambrano, J., Heldman, A., and Hare, J., Rationale and Design of the Transendocardial Injection of Autologous Human Cells (Bone Marrow or Mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) Trial [..], Am Heart J, vol. 161, pp. 487-493, 2011.
A. Howard, Fernandez-Vina, M. A., Appelbaum, F. R., Confer, D. L., Devine, S. M., Horowitz, M. M., Mendizabal, A., Laport, G. G., Pasquini, M. C., and , Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Biol Blood Marrow Transplant, vol. 21, no. 1, pp. 4-7, 2014.